Sandalwood China E-Commerce Data shows COVID-related drug sales on JD reached 96.93 million RMB (around 13.91 million USD) in last week of Nov, representing a 465.02% y/y growth compared to 2021. Sales of cold and cough medicine grew 380.18% y/y and reached 60.17 million RMB (around 8.64 million USD), whereas Antipyretic and Analgesia grew 694.82% y/y and reached 36.77 million RMB (around 5.28 million USD).
COVID-related medical equipment sales grew 97.6% y/y on JD in the same period and reached 72.35 million RMB (10.38 million USD), among which Oxygen Machine/Bags/Bottles grew 88.65% y/y to 67.25 million RMB (around 9.65 million USD) and Oximeter grew 427.62% y/y to 5.1 million RMB (around 731.8k USD).
The above data is published in Sandalwood China Coronavirus Impact Analysis Live Report, which monitors real-time COVID situation impact on key sectors including luxury, housing, hotel, restaurant, automobile, e-commerce etc. in China. Stay tuned!
To learn more about the data behind this article and what Sandalwood has to offer, visit http://www.sandalwoodadvisors.com.
Sign up to receive our stories in your inbox.
Data is changing the speed of business. Investors, Corporations, and Governments are buying new, differentiated data to gain visibility make better decisions. Don't fall behind. Let us help.
Sign up to receive our stories in your inbox.
Data is changing the speed of business. Investors, Corporations, and Governments are buying new, differentiated data to gain visibility make better decisions. Don't fall behind. Let us help.
